Quantitative analysis of bronchial wall vascularity in the medium and small airways of patients with asthma and COPD.

BACKGROUND Submucosal hypervascularity is part of airway remodeling in patients with asthma; however, its existence in the small airways and its contribution to airflow limitation remain controversial. METHODS We investigated bronchial wall vascularity and angiogenic cells between medium airways (inner diameter, 2 to 5 mm) and small airways (inner diameter, < 2 mm) in patients with asthma (n = 9) and COPD (n = 11), and in 8 control subjects. The lung specimens obtained during surgery were immunostained to detect CD31, CD34, vascular endothelial growth factor, and basic fibroblast growth factor. RESULTS The number of vessels in both the medium and small airways in patients with asthma was significantly (p < 0.01) increased compared to those in patients with COPD and control subjects, and the percentage of vascularity was significantly (p < 0.01) increased in the medium airways in asthma patients and in the small airways in COPD patients. Patients with moderate asthma showed a greater increase in vascularity than those with mild asthma (p < 0.01), and the number of angiogenic factor-positive cells increased in asthma patients compared with control subjects. In asthmatic subjects, inverse correlations were found between FEV(1) percentage of predicted and the number of vessels (r = -0.85; p < 0.01), or the percentage of vascularity (r = -0.72; p < 0.03) in the inner area of the medium airways, but they were not found for the small airways. In COPD patients, no correlations were demonstrated. CONCLUSIONS The number of vessels in the medium and small airways in asthma patients shows a greater increase than those in COPD patients, and the vascular area in the small airways is increased in COPD patients but not in asthma patients. Enhanced vascularity in the inner area of the medium airways, but not in the small airways, might contribute to airflow limitation in asthma patients.

[1]  E. Weibel.  Morphometry of the Human Lung , 1965, Springer Berlin Heidelberg.

[2]  P. Paré,et al.  The effect of submucosal edema on airways resistance. , 2015, The American review of respiratory disease.

[3]  P. Paré,et al.  Small airway dimensions in smokers with obstruction to airflow. , 1990, The American review of respiratory disease.

[4]  P. Paré,et al.  Small airways dimensions in asthma and in chronic obstructive pulmonary disease. , 1993, The American review of respiratory disease.

[5]  J. Folkman.  Clinical Applications of Research on Angiogenesis , 1995 .

[6]  B. Make,et al.  Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease. American Thoracic Society. , 1995, American journal of respiratory and critical care medicine.

[7]  A. James,et al.  The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics. , 1997, The European respiratory journal.

[8]  A. James,et al.  Bronchial blood vessel dimensions in asthma. , 1997, American journal of respiratory and critical care medicine.

[9]  J. Hogg,et al.  Inflammation of small airways in asthma. , 1997, The Journal of allergy and clinical immunology.

[10]  J. Wilson,et al.  Increased vascularity of the bronchial mucosa in mild asthma. , 1997, American journal of respiratory and critical care medicine.

[11]  Bousquet,et al.  VEGF levels in asthmatic airways do not correlate with plasma extravasation , 1999, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[12]  F. Thien,et al.  Vascularity in asthmatic airways: relation to inhaled steroid dose. , 1999, Thorax.

[13]  R. Djukanović,et al.  Bronchial angiogenesis in severe glucocorticoid-dependent asthma. , 2000, The European respiratory journal.

[14]  J Bousquet,et al.  Asthma. From bronchoconstriction to airways inflammation and remodeling. , 2000, American journal of respiratory and critical care medicine.

[15]  N. Aoike,et al.  Inhaled corticosteroids decrease vascularity of the bronchial mucosa in patients with asthma , 2001, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[16]  N. Aoike,et al.  Expression of vascular endothelial growth factor, basic fibroblast growth factor, and angiogenin immunoreactivity in asthmatic airways and its relationship to angiogenesis. , 2001, The Journal of allergy and clinical immunology.

[17]  F. Thien,et al.  Effect of a long-acting beta2-agonist over three months on airway wall vascular remodeling in asthma. , 2001, American journal of respiratory and critical care medicine.

[18]  G Salvato,et al.  Quantitative and morphological analysis of the vascular bed in bronchial biopsy specimens from asthmatic and non-asthmatic subjects , 2001, Thorax.

[19]  R. Pauwels,et al.  Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO Global Initiative for Chronic Obstructive Lung Disease (GOLD) Workshop summary. , 2001, American journal of respiratory and critical care medicine.

[20]  S. Wenzel,et al.  Transbronchial biopsy as a tool to evaluate small airways in asthma , 2002, European Respiratory Journal.

[21]  K. Hirata,et al.  Imbalance between vascular endothelial growth factor and endostatin levels in induced sputum from asthmatic subjects. , 2002, The Journal of allergy and clinical immunology.

[22]  R. D'Ippolito,et al.  Vascular component of airway remodeling in asthma is reduced by high dose of fluticasone. , 2003, American journal of respiratory and critical care medicine.

[23]  P. Howarth,et al.  Pharmacotherapy and airway remodelling in asthma? , 2003, Thorax.

[24]  K. Hirata,et al.  Possible effects of vascular endothelial growth factor in the pathogenesis of chronic obstructive pulmonary disease. , 2003, The American journal of medicine.

[25]  Hiroshi Tanaka,et al.  Increased airway vascularity in newly diagnosed asthma using a high-magnification bronchovideoscope. , 2003, American journal of respiratory and critical care medicine.